What is the appropriate cefixime dosage for treating typhoid fever in adults and children, and how should it be adjusted in patients with renal impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cefixime Dosing for Typhoid Fever

For uncomplicated typhoid fever, cefixime should be dosed at 20 mg/kg/day orally divided into two doses (maximum 400 mg twice daily) for 7-14 days in children, and 400 mg daily (200 mg twice daily) for 7-10 days in adults. 1, 2

Adult Dosing

  • Standard dose: 400 mg daily (can be given as 200 mg twice daily), administered orally for 7-10 days 1, 2
  • The capsule may be taken without regard to food 2
  • Treatment duration of at least 7 days is recommended for typhoid fever 1

Pediatric Dosing (≥6 months)

  • 20 mg/kg/day divided into two doses (maximum 400 mg/day) 1, 2
  • Administer as 10 mg/kg every 12 hours 2
  • Treatment duration: 7-14 days based on clinical response 1, 3, 4
  • Children weighing >45 kg or >12 years should receive the adult dose 2

Weight-Based Dosing Table for Children

For practical administration using oral suspension 2:

  • 5-7.5 kg: 50 mg/day (2.5 mL of 100 mg/5 mL suspension)
  • 7.6-10 kg: 80 mg/day (4 mL of 100 mg/5 mL or 2 mL of 200 mg/5 mL)
  • 10.1-12.5 kg: 100 mg/day (5 mL of 100 mg/5 mL or 2.5 mL of 200 mg/5 mL)
  • 12.6-20.5 kg: 150 mg/day (7.5 mL of 100 mg/5 mL or 4 mL of 200 mg/5 mL)
  • 20.6-28 kg: 200 mg/day (10 mL of 100 mg/5 mL or 5 mL of 200 mg/5 mL)
  • >45 kg: 400 mg/day (adult dose)

Renal Impairment Adjustments

Dose adjustment is essential in renal impairment 2:

  • CrCl ≥60 mL/min: Normal dose (no adjustment needed) 2
  • CrCl 21-59 mL/min OR hemodialysis: Reduce to 260 mg daily (13 mL of 100 mg/5 mL suspension or 6.5 mL of 200 mg/5 mL suspension) 2
  • CrCl ≤20 mL/min OR continuous peritoneal dialysis: Reduce to 172 mg daily (8.6 mL of 100 mg/5 mL suspension or 4.4 mL of 200 mg/5 mL suspension) 2

Neither hemodialysis nor peritoneal dialysis removes significant amounts of cefixime from the body 2

Clinical Efficacy Considerations

Cefixime is less effective than fluoroquinolones but remains a viable oral option, particularly in settings where fluoroquinolone resistance is not prevalent 5, 6:

  • Clinical cure rates of 62-95% have been reported with cefixime in multidrug-resistant typhoid 7, 3, 4
  • Fever clearance time with cefixime (mean 5.3-8.5 days) is longer compared to fluoroquinolones (4.4 days) or azithromycin (5.8 days) 7, 5, 3
  • Treatment failures occur in approximately 10-25% of cases, higher than with fluoroquinolones 5, 6
  • Relapse rates of 4-25% have been observed 3, 6

Important Clinical Caveats

  • Cefixime should NOT be used as first-line therapy in areas with high fluoroquinolone resistance or extensively drug-resistant (XDR) typhoid, as azithromycin or carbapenems are preferred 8
  • The oral suspension formulation is preferred over tablets/capsules in children, as it achieves higher peak blood levels 2
  • Treatment duration should be at least 10-14 days for optimal outcomes, particularly in multidrug-resistant cases 3, 4
  • Monitor for treatment failure (persistent fever beyond 7 days) and consider switching to alternative antimicrobials 7, 5
  • Local antimicrobial susceptibility patterns must guide therapy selection 2, 8, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.